EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas

Camilo Jimenez iD, Rene Baudrand, Thomas Uslar iD, Daniel Bulzico

Therapeutic Advances in Medical Oncology · 2024-10 · 16

DOI: 10.1177/17588359241301359 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 21.11.2024. Verfasst von Camilo Jimenez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1461, Houston…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pheochromocytomas and paragangliomas (PPGLs) are orphan tumors with the potential to spread to distant organs such as the lymph nodes, the skeleton, the lungs, and the liver. These metastatic tumors exhibit high rates of morbidity and mortality due to their frequently large tumor burden, the progression of the disease, and the excessive secretion of catecholamines that lead to cardiovascular disease and gastrointestinal dysmotility. Several molecular drivers responsible for the development of PPGLs have been described over the last 30 years. Although therapeutic options are limited, substantial progress has been made in the recognition of effective systemic therapies for these tumors. Successful clinical trials with radiopharmaceuticals such as high-specific-activity meta-iodobenzylguanidine and tyrosine kinase inhibitors such as cabozantinib and sunitinib have been recently published. This review will discuss the results of these studies and their impact on current clinical practices. In addition, this review will provide valuable information on how to design clinical trials to treat patients with metastatic PPGLs with novel medications.

Schlagwörter

Stichwörter der Autor:innen

metastatic pheochromocytoma and paragangliomaradiopharmaceuticalstyrosine kinase inhibitors

Autor:innen und Institutionen

  • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1461, Houston, TX 77030, USA.
  • Department of Endocrinology, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Department of Nuclear Medicine and Endocrine Oncology, Brazilian National Cancer Institute, Rio de Janeiro, Brazil.

ORCID-Profile: Camilo Jimenez, Thomas Uslar

Zitieren

APA

Jimenez, C., Baudrand, R., Uslar, T., & Bulzico, D. (2024). Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas. Therapeutic Advances in Medical Oncology, 16. https://doi.org/10.1177/17588359241301359

Vancouver

Jimenez C, Baudrand R, Uslar T, Bulzico D. Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241301359

BibTeX
@article{Jimenez2024,
  author = {Jimenez, Camilo and Baudrand, Rene and Uslar, Thomas and Bulzico, Daniel},
  title = {Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2024},
  volume = {16},
  doi = {10.1177/17588359241301359}
}
Kostenlos starten →